Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes
Clinical trial NCT04556760 · COMPLETED
Trial details
- NCT number
- NCT04556760
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-26
- Primary completion
- 2021-06-09
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.